Most of Lilly’s Mounjaro and Zepbound doses in limited supply, FDA says
According to the agency’s website, most doses of Eli Lilly’s diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand.